Inventor
REY ALLAN W
CA30 patents
⚠️ This page may combine multiple inventors who share the name “REY ALLAN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
APOTEX INC
15 patentsUS11377456B2Jul 5, 2022
Crystalline form of Remdesivir
APOTEX INC16 citations83
US10183024B2Jan 22, 2019
Crystalline forms of ibrutinib
APOTEX INC2 citations71
US11814356B1Nov 14, 2023
Salt of cabozantinib
APOTEX INC0 citations60
US11236066B2Feb 1, 2022
Crystalline forms of niraparib tosylate
APOTEX INC1 citations60
US11072620B2Jul 27, 2021
Crystalline forms of Ponatinib hydrochloride
APOTEX INC0 citations59
US11046638B2Jun 29, 2021
Processes for the preparation of zuclomiphene and intermediates thereof
APOTEX INC1 citations59
US11661396B2May 30, 2023
Crystalline forms of zuclomiphene citrate
APOTEX INC0 citations57
US11578025B2Feb 14, 2023
Processes for the preparation of zuclomiphene intermediates
APOTEX INC0 citations56
US11220500B2Jan 11, 2022
Crystalline form of Valbenazine dibesylate
APOTEX INC0 citations56
US10513500B2Dec 24, 2019
Crystalline forms of Lesinurad
APOTEX INC1 citations56
US10632107B2Apr 28, 2020
Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2
APOTEX INC0 citations51
US10662178B2May 26, 2020
Crystalline form of Olaparib
APOTEX INC0 citations50
US9382233B2Jul 5, 2016
Forms of vilazodone and processes for the preparation thereof
APOTEX INC1 citations50
US10407396B2Sep 10, 2019
Crystalline form of selexipag
APOTEX INC0 citations48
US12583860B2Mar 24, 2026
Processes for the preparation of multicomponent crystalline forms of active pharmaceutical ingredients using solvent vapour
APOTEX INC0 citations47
APOTEX PHARMACHEM INC
7 patentsUS7935817B2May 3, 2011
Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
APOTEX PHARMACHEM INC24 citations90
US7834195B2Nov 16, 2010
Atorvastatin calcium propylene glycol solvates
APOTEX PHARMACHEM INC2 citations60
US7087611B2Aug 8, 2006
Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride)
APOTEX PHARMACHEM INC2 citations60
US7138523B2Nov 21, 2006
Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-aralkylnipecotinate esters
APOTEX PHARMACHEM INC2 citations58
US7375233B2May 20, 2008
Process for the preparation of zonisamide and the intermediates thereof
APOTEX PHARMACHEM INC0 citations48
US7939662B2May 10, 2011
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
APOTEX PHARMACHEM INC0 citations43
US7696183B2Apr 13, 2010
Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
APOTEX PHARMACHEM INC0 citations34
BRISTOL MYERS SQUIBB CO
2 patentsBRANTFORD CHEM INC
2 patentsUS5962689AOct 5, 1999
Stereoselective and useful preparation of 3-substituted 4-aryl piperidine compounds
BRANTFORD CHEM INC6 citations62
US6132286AOct 17, 2000
Preparation of 1,2,5,6-tetra-hydro-3-carboalkoxypridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypridines and arecoline hydrobromide
BRANTFORD CHEM INC4 citations51